Keybanc analyst John Vinh maintains Advanced Micro Devices (NASDAQ:AMD) with a Overweight and lowers the price target from $85 to $80.
Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today?
Vivos Therapeutics Inc (NASDAQ: VVOS) received FDA 510(k) clearance for treating severe obstructive sleep apnea (OSA) in adults using the Vivos' removable CARE (Complete Airway Repositioning and/or Expansion)